View:
Download DOC
Download PDF
Download XLS
SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Revolution Medicines, Inc.

(Name of Issuer)

Common Stock, par value $0.0001

(Title of Class of Securities)

76155X100

(CUSIP Number)

February 13, 2020

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

CUSIP No. 76155X100    Page 2 of 10

 

  1    

  Name of reporting persons.

 

  Boxer Capital, LLC

  2  

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3  

  SEC use only.

 

  4  

  Citizenship or place of organization.

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH:

    5      

  Sole voting power.

 

  -0-

   6    

  Shared voting power.

 

  3,159,764

   7    

  Sole dispositive power.

 

  -0-

   8   

  Shared dispositive power.

 

  3,159,764

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  3,159,764

10  

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11  

  Percent of class represented by amount in row (9).

 

  5.6%*

12  

  Type of reporting person

 

  OO

 

*

Based on 56,902,309 shares of common stock outstanding after the Issuer’s initial public offering, as set forth in the Issuer’s preliminary prospectus filed with the SEC on February 11, 2020 (the “Preliminary Prospectus”), assuming no exercise of the underwriters’ overallotment option to purchase 2,100,000 shares of Common Stock within 30 days of the date of the Preliminary Prospectus.

CUSIP No. 76155X100    Page 3 of 10

 

  1    

  Name of reporting persons.

 

  Boxer Asset Management Inc.

  2  

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3  

  SEC use only.

 

  4  

  Citizenship or place of organization.

 

  Bahamas

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH:

    5      

  Sole voting power.

 

  -0-

   6    

  Shared voting power.

 

  3,159,764

   7    

  Sole dispositive power.

 

  -0-

   8   

  Shared dispositive power.

 

  3,159,764

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  3,159,764

10  

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11  

  Percent of class represented by amount in row (9).

 

  5.6%*

12  

  Type of reporting person

 

  CO

 

*

Based on 56,902,309 shares of common stock outstanding after the Issuer’s initial public offering, as set forth in Preliminary Prospectus, assuming no exercise of the underwriters’ overallotment option to purchase 2,100,000 shares of Common Stock within 30 days of the date of the Preliminary Prospectus.

CUSIP No. 76155X100    Page 4 of 10

 

  1    

  Name of reporting persons.

 

  Joe Lewis

  2  

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3  

  SEC use only.

 

  4  

  Citizenship or place of organization.

 

  United Kingdom

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH:

    5      

  Sole voting power.

 

  -0-

   6    

  Shared voting power.

 

  3,159,764

   7    

  Sole dispositive power.

 

  -0-

   8   

  Shared dispositive power.

 

  3,159,764

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  3,159,764

10  

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11  

  Percent of class represented by amount in row (9).

 

  5.6%*

12  

  Type of reporting person

 

  IN

 

*

Based on 56,902,309 shares of common stock outstanding after the Issuer’s initial public offering, as set forth in Preliminary Prospectus, assuming no exercise of the underwriters’ overallotment option to purchase 2,100,000 shares of Common Stock within 30 days of the date of the Preliminary Prospectus.

CUSIP No. 76155X100    Page 5 of 10

 

  1    

  Name of reporting persons.

 

  MVA Investors, LLC

  2  

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3  

  SEC use only.

 

  4  

  Citizenship or place of organization.

 

  Delaware

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH:

    5      

  Sole voting power.

 

  -0-

   6    

  Shared voting power.

 

  35,414

   7    

  Sole dispositive power.

 

  -0-

   8   

  Shared dispositive power.

 

  35,414

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  35,414

10  

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11  

  Percent of class represented by amount in row (9).

 

  0.1%*

12  

  Type of reporting person

 

  OO

 

*

Based on 56,902,309 shares of common stock outstanding after the Issuer’s initial public offering, as set forth in Preliminary Prospectus, assuming no exercise of the underwriters’ overallotment option to purchase 2,100,000 shares of Common Stock within 30 days of the date of the Preliminary Prospectus.

CUSIP No. 76155X100    Page 6 of 10

 

  1    

  Name of reporting persons.

 

  Aaron I. Davis

  2  

  Check the appropriate box if a member of a group. (See instructions)

  (a)  ☐        (b)  ☒

 

  3  

  SEC use only.

 

  4  

  Citizenship or place of organization.

 

  United States

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

EACH

REPORTING

PERSON

WITH:

    5      

  Sole voting power.

 

  -0-

   6    

  Shared voting power.

 

  35,414

   7    

  Sole dispositive power.

 

  -0-

   8   

  Shared dispositive power.

 

  35,414

  9    

  Aggregate amount beneficially owned by each reporting person.

 

  35,414

10  

  Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

 

  ☐

11  

  Percent of class represented by amount in row (9).

 

  0.1%*

12  

  Type of reporting person

 

  IN

 

*

Based on 56,902,309 shares of common stock outstanding after the Issuer’s initial public offering, as set forth in Preliminary Prospectus, assuming no exercise of the underwriters’ overallotment option to purchase 2,100,000 shares of Common Stock within 30 days of the date of the Preliminary Prospectus.

   Page 7 of 10

 

Item 1(a).

Name of Issuer:

Revolution Medicines, Inc. (the “Issuer”)

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

700 Saginaw Drive

Redwood City, CA 94063

 

Item 2(a).

Name of Person Filing:

This Schedule 13G is jointly filed by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”), MVA Investors, LLC (“MVA Investors”), Aaron I. Davis (“Aaron Davis”) and Joe Lewis (together with Boxer Capital, Boxer Management, MVA Investors and Aaron Davis, the “Reporting Persons”). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management. MVA Investors is the independent, personal investment vehicle of certain employees of Boxer Capital. Aaron Davis is a member of and has voting and dispositive power over securities held by MVA Investors.

 

Item 2(b).

Address of Principal Business Office, or, if none, Residence:

The principal business address of Boxer Capital, MVA Investors and Aaron Davis is: 11682 El Camino Real, Suite 320, San Diego, CA 92130. The principal business address of Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.

 

Item 2(c).

Citizenship:

Boxer Capital is a limited liability company organized under the laws of Delaware. Boxer Management is a corporation organized under the laws of the Bahamas. MVA Investors is a limited liability company organized under the laws of Delaware. Aaron Davis is a citizen of the United States. Joe Lewis is a citizen of the United Kingdom.

 

Item 2(d).

Title of Class of Securities:

Common stock, par value $0.0001 (the “Common Stock”)

 

Item 2(e).

CUSIP Number:

76155X100

 

Item 3.

If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

Not applicable.

 

Item 4.

Ownership.

 

  (a)

Amount beneficially owned:

Boxer Capital, Boxer Management and Joe Lewis beneficially own 3,159,764 shares of Common Stock. MVA Investors and Aaron Davis beneficially own 35,414 shares of Common Stock. The Reporting Persons beneficially own, in the aggregate, 3,195,178 shares of Common Stock.

   Page 8 of 10

 

  (b)

Percent of class:

The number of shares of Common Stock beneficially owned by Boxer Capital, Boxer Management and Joe Lewis represent 5.6% of the Issuer’s outstanding Common Stock. The number of shares of Common Stock beneficially owned by MVA Investors and Aaron Davis represent 0.1% of the Issuer’s outstanding Common Stock. The number of shares of Common Stock beneficially owned by the Reporting Persons represent, in the aggregate, 5.6% of the Issuer’s outstanding Common Stock. All percentages are based on 56,902,309 shares of common stock outstanding after the Issuer’s initial public offering, as set forth in Preliminary Prospectus, assuming no exercise of the underwriters’ overallotment option to purchase 2,100,000 shares of Common Stock within 30 days of the date of the Preliminary Prospectus.

 

  (c)

Number of shares as to which such person has:

 

  (i)

Sole power to vote or to direct the vote:

None of the Reporting Persons has sole power to vote or to direct the vote of any shares of Common Stock.

 

  (ii)

Shared power to vote or to direct the vote:

Boxer Capital, Boxer Asset Management and Joe Lewis have shared power to vote or to direct the vote of the 3,159,764 shares of Common Stock they beneficially own. MVA Investors and Aaron Davis have shared power to vote or to direct the vote of the 35,414 shares of Common Stock they beneficially own.

 

  (iii)

Sole power to dispose or to direct the disposition of:

None of the Reporting Persons has sole power to dispose or to direct the disposition of any shares of Common Stock.

 

  (iv)

Shared power to dispose or to direct the disposition of:

Boxer Capital, Boxer Asset Management and Joe Lewis have shared power to dispose or to direct the disposition of the 3,159,764 shares of Common Stock they beneficially own. MVA Investors and Aaron Davis have the sole power to dispose or to direct the disposition of the 35,414 shares of Common Stock they beneficially own.

 

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Only Boxer Capital has the right to receive dividends and the proceeds from the sale of the shares of Common Stock held by Boxer Capital. Only MVA Investors has the right to receive dividends and the proceeds from the sale of the shares of Common Stock held by MVA Investors.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

Not applicable.

   Page 9 of 10

 

Item 9.

Notice of Dissolution of Group.

Not applicable.

 

Item 10.

Certification.

(c) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Exhibits

 

1

Joint Filing Agreement, dated February 13, 2020, among the Reporting Persons.

   Page 10 of 10

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 13, 2020

 

BOXER CAPITAL, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Chief Executive Officer

 

BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director

 

JOSEPH C. LEWIS

/s/ Joseph C. Lewis

Joseph C. Lewis, Individually

 

MVA INVESTORS, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Authorized Signatory

 

AARON I. DAVIS

/s/ Aaron I. Davis

Aaron I. Davis, Individually

 

EX-99.1

Exhibit 1

JOINT FILING AGREEMENT

The undersigned hereby agree that the Statement on Schedule 13G with respect to the Common Stock of Revolution Medicines, Inc., par value $0.0001, is, and any amendments thereto executed by each of us shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to the Schedule 13G and each such amendment. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of February 13, 2020.

 

BOXER CAPITAL, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Chief Executive Officer
BOXER ASSET MANAGEMENT INC.
By:  

/s/ Jason Callender

Name:   Jason Callender
Title:   Director

 

JOSEPH C. LEWIS

/s/ Joseph C. Lewis

Joseph C. Lewis, Individually

 

MVA INVESTORS, LLC
By:  

/s/ Aaron I. Davis

Name:   Aaron I. Davis
Title:   Authorized Signatory

 

AARON I. DAVIS

/s/ Aaron I. Davis

Aaron I. Davis, Individually